
But K-beauty is not a separate regulatory category in the European Union. Once a Korean cosmetic product is placed on the EU market, its claims must comply with the same requirements that apply to any other cosmetic product.
The six common criteria are legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. These principles are particularly relevant to the highly visual and benefit-focused marketing often associated with K-beauty.
“Glass skin” is a useful example of why context matters.
The expression is widely understood as a beauty concept associated with skin that appears smooth, hydrated, luminous and even. It is not, by itself, a regulated EU claim or an automatically prohibited expression.
However, the overall presentation matters. A brand should be able to demonstrate that the product can deliver the cosmetic effect communicated to consumers. Regulation requires claims to have adequate and verifiable evidence, with the level of substantiation appropriate to the nature of the claim.
A general aesthetic expression may therefore be treated differently from a specific performance claim such as “reduces wrinkles by 40%” or “increases skin hydration by 50%.” The more precise and measurable the claim, the more important it becomes to have appropriate evidence supporting the finished product.
Ingredient Claims Must Not Overstate the Finished Product
K-beauty products frequently highlight specific ingredients such as snail secretion filtrate, niacinamide, centella asiatica, fermented ingredients, rice extracts or peptides.
Under the EU claims framework, simply demonstrating that an ingredient is present is not necessarily enough to substantiate a claim about the finished cosmetic.
Regulation 655/2013 specifically states that ingredient claims must not imply that the finished product has the same properties as the ingredient when it does not. Where an ingredient property is extrapolated to the finished product, adequate and verifiable evidence is required.
This is particularly important for marketing based heavily on an ingredient’s reputation. A product containing a well-known active ingredient should not automatically be presented as delivering every benefit associated with that ingredient in isolation.
“Whitening” and Other Sensitive Claims Require Careful Assessment
Some terminology commonly used in Asian cosmetic markets can also create challenges when adapted for European consumers.
For example, terms translated as “whitening,” “skin lightening” or “brightening” should be assessed according to the precise meaning conveyed by the finished communication. A cosmetic claim concerning the appearance or radiance of the skin is not necessarily equivalent to a claim concerning a biological or therapeutic alteration of pigmentation.
Similarly, claims relating to acne, inflammation, eczema, skin disease or other medical conditions require particular attention. The EU cosmetics framework applies to products that meet the legal definition of a cosmetic; claims that move toward treating or preventing disease can raise questions about whether the product remains within that definition.
Social Media and Influencer Content Also Counts
For K-beauty brands, compliance cannot be limited to the wording printed on the packaging.
Claims appearing on websites, social media, influencer content, advertisements, product pages and other communications can all contribute to the overall presentation of a cosmetic product. Regulation applies regardless of the marketing medium or type of marketing tool used.
This means that a compliant label can still be accompanied by problematic online claims. Manufacturers and responsible persons should therefore review the complete marketing environment, rather than assessing packaging in isolation.
What K-Beauty Brands Should Check Before Entering the EU
For Korean manufacturers entering the European market, claims review should form part of the regulatory assessment from the beginning.
The brand should first identify the exact claims it intends to make and determine what consumers are likely to understand from them. The next step is to verify that the finished product can support those claims through appropriate evidence. Particular attention should be given to quantitative efficacy claims, ingredient-based claims, before-and-after presentations and claims that could suggest a therapeutic effect.
It is also important to remember that European cosmetic compliance is not simply a translation exercise. A claim that is accepted or commonly used in Korea does not automatically meet EU requirements.